Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,749 public trials 1,059 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Active, Not Recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Exelixis Clinical Site #2 Newport Beach, California, United States
  • Exelixis Clinical Site #98 Sacramento, California, United States
  • Exelixis Clinical Site #69 San Francisco, California, United States
  • Exelixis Clinical Site #10 Stanford, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

NCT05814549

Conditions
HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma, Head and Neck Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

NCT05241834

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine-Comprehensive Cancer Center Chicago, Illinois, United States
View all 16 locations
View Trial Details

Related conditions